SELENIOUS ACID Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Selenious Acid, and when can generic versions of Selenious Acid launch?
Selenious Acid is a drug marketed by Am Regent and is included in one NDA.
The generic ingredient in SELENIOUS ACID is selenious acid. One supplier is listed for this compound. Additional details are available on the selenious acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Selenious Acid
A generic version of SELENIOUS ACID was approved as selenious acid by AM REGENT on April 30th, 2019.
Summary for SELENIOUS ACID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,353 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in SELENIOUS ACID? | SELENIOUS ACID excipients list |
| DailyMed Link: | SELENIOUS ACID at DailyMed |
Recent Clinical Trials for SELENIOUS ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| American Regent, Inc. | Phase 4 |
| Shanghai Changzheng Hospital | N/A |
| Shanghai Zhongshan Hospital | N/A |
US Patents and Regulatory Information for SELENIOUS ACID
SELENIOUS ACID is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting SELENIOUS ACID
NEW CHEMICAL ENTITY
Exclusivity Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-003 | Aug 30, 2021 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-002 | Jan 25, 2021 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Am Regent | SELENIOUS ACID | selenious acid | SOLUTION;INTRAVENOUS | 209379-001 | Apr 30, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
